WFG Advisors’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | $989K | Buy |
29,784
+28,701
| +2,650% | +$953K | 0.22% | 110 |
|
|
2017
Q1 | $35K | Sell |
1,083
-868
| -44% | -$28.1K | 0.01% | 759 |
|
|
2016
Q4 | $71K | Sell |
1,951
-143
| -7% | -$5.2K | 0.02% | 630 |
|
|
2016
Q3 | $96K | Buy |
2,094
+14
| +0.7% | +$642 | 0.02% | 532 |
|
|
2016
Q2 | $104K | Buy |
2,080
+256
| +14% | +$12.8K | 0.03% | 486 |
|
|
2016
Q1 | $98K | Buy |
1,824
+6
| +0.3% | +$322 | 0.03% | 474 |
|
|
2015
Q4 | $119K | Sell |
1,818
-94
| -5% | -$6.15K | 0.04% | 428 |
|
|
2015
Q3 | $108K | Sell |
1,912
-252
| -12% | -$14.2K | 0.03% | 446 |
|
|
2015
Q2 | $128K | Buy |
2,164
+12
| +0.6% | +$710 | 0.04% | 466 |
|
|
2015
Q1 | $134K | Sell |
2,152
-1,592
| -43% | -$99.1K | 0.04% | 447 |
|
|
2014
Q4 | $215K | Buy |
3,744
+76
| +2% | +$4.36K | 0.04% | 407 |
|
|
2014
Q3 | $197K | Sell |
3,668
-80
| -2% | -$4.3K | 0.04% | 455 |
|
|
2014
Q2 | $196K | Buy |
3,748
+339
| +10% | +$17.7K | 0.04% | 451 |
|
|
2014
Q1 | $180K | Sell |
3,409
-1,625
| -32% | -$85.8K | 0.04% | 461 |
|
|
2013
Q4 | $202K | Buy |
5,034
+809
| +19% | +$32.5K | 0.03% | 516 |
|
|
2013
Q3 | $160K | Buy |
4,225
+499
| +13% | +$18.9K | 0.02% | 553 |
|
|
2013
Q2 | $146K | Buy |
+3,726
| New | +$146K | 0.02% | 548 |
|